DD234417A5 - Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel - Google Patents

Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel Download PDF

Info

Publication number
DD234417A5
DD234417A5 DD85273087A DD27308785A DD234417A5 DD 234417 A5 DD234417 A5 DD 234417A5 DD 85273087 A DD85273087 A DD 85273087A DD 27308785 A DD27308785 A DD 27308785A DD 234417 A5 DD234417 A5 DD 234417A5
Authority
DD
German Democratic Republic
Prior art keywords
carbons
alkyl
oxindole
formula
thienyl
Prior art date
Application number
DD85273087A
Other languages
German (de)
English (en)
Inventor
Saul B Kadin
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD234417A5 publication Critical patent/DD234417A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DD85273087A 1984-02-07 1985-02-06 Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel DD234417A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57790384A 1984-02-07 1984-02-07

Publications (1)

Publication Number Publication Date
DD234417A5 true DD234417A5 (de) 1986-04-02

Family

ID=24310612

Family Applications (2)

Application Number Title Priority Date Filing Date
DD85273087A DD234417A5 (de) 1984-02-07 1985-02-06 Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel
DD86288635A DD244133A5 (de) 1984-02-07 1986-04-01 Verfahren zur herstellung von substituierten 2-oxindolen als analgetische und entzuendungshemmende mittel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DD86288635A DD244133A5 (de) 1984-02-07 1986-04-01 Verfahren zur herstellung von substituierten 2-oxindolen als analgetische und entzuendungshemmende mittel

Country Status (14)

Country Link
US (1) US4658037A (no)
JP (1) JPS60248669A (no)
KR (2) KR880000433B1 (no)
BG (3) BG40963A3 (no)
CS (1) CS252480B2 (no)
DD (2) DD234417A5 (no)
HU (1) HU194166B (no)
IN (1) IN163263B (no)
MW (1) MW185A1 (no)
PL (3) PL145230B1 (no)
RO (2) RO90621A2 (no)
YU (3) YU43866B (no)
ZA (1) ZA85888B (no)
ZM (1) ZM785A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4808601A (en) * 1984-09-19 1989-02-28 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
WO1990008145A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
US5086186A (en) * 1989-05-25 1992-02-04 Pfizer Inc. N-trichloroacetyl-2-oxindole-1-carboxamides
US4952703A (en) * 1989-05-25 1990-08-28 Pfizer Inc. Intermediates for making 2-oxindole-1-carboxamides
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
ES2097025T3 (es) * 1993-02-09 1997-03-16 Pfizer Oxindol 1-(n-(alcoxicarbonil))carboxamidas y 1-(n-carboxamido)carboxamidas como agentes antiinflamatorios.
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
JP2009040790A (ja) * 2008-08-29 2009-02-26 Ube Ind Ltd 5−フルオロオキシインドールの製造法
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
EA024559B1 (ru) 2009-05-06 2016-09-30 Лаборэтори Скин Кэа, Инк. Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103570604B (zh) * 2012-07-21 2015-10-07 重庆圣华曦药业股份有限公司 齐拉西酮中间体的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3462450A (en) * 1966-06-29 1969-08-19 Merck & Co Inc Chemical compounds
GB1158532A (en) * 1967-01-05 1969-07-16 Centre Nat Rech Scient 2-Oxoindoline-3-Carboxylic Acids and Esters thereof
US3631177A (en) * 1967-04-18 1971-12-28 Smith Kline French Lab 3-phenacyl-2-oxoindolines
US3519592A (en) * 1967-04-18 1970-07-07 Smithkline Corp Indole compounds
BE714717A (no) * 1967-05-12 1968-09-30
FR7337M (no) * 1968-01-11 1969-10-13
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US3975531A (en) * 1973-10-02 1976-08-17 A. H. Robins Company, Incorporated 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof
US4221716A (en) * 1979-02-16 1980-09-09 A. H. Robins Company, Inc. Intermediate and process for the preparation of 7-acylindolin-2-ones

Also Published As

Publication number Publication date
PL255465A1 (en) 1986-07-15
CS78585A2 (en) 1987-01-15
KR850005824A (ko) 1985-09-26
RO93218B (ro) 1988-01-01
ZM785A1 (en) 1985-08-22
CS252480B2 (en) 1987-09-17
RO90621A2 (ro) 1986-12-10
YU198187A (en) 1988-10-31
DD244133A5 (de) 1987-03-25
US4658037A (en) 1987-04-14
KR880000434B1 (ko) 1988-03-24
HU194166B (en) 1988-01-28
PL145310B1 (en) 1988-09-30
PL145196B1 (en) 1988-08-31
JPH0413340B2 (no) 1992-03-09
RO93218A (ro) 1987-12-31
MW185A1 (en) 1986-04-09
BG43865A3 (en) 1988-08-15
KR880000433B1 (ko) 1988-03-24
YU18085A (en) 1988-04-30
PL251869A1 (en) 1985-12-17
BG44204A3 (en) 1988-10-14
YU46320B (sh) 1993-05-28
YU44062B (en) 1990-02-28
BG40963A3 (en) 1987-03-14
JPS60248669A (ja) 1985-12-09
YU129087A (en) 1988-02-29
IN163263B (no) 1988-08-27
ZA85888B (en) 1986-09-24
YU43866B (en) 1989-12-31
PL145230B1 (en) 1988-08-31

Similar Documents

Publication Publication Date Title
EP0763037B1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
EP0164860B1 (en) N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
DD234417A5 (de) Verfahren zur herstellung von 1,3-disubstituerten 2-oxindoeln als analytische und entzuendungshemmende mittel
EP0175551B1 (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4721712A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
EP0804437B1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
EP0763036B1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
AT376976B (de) Verfahren zur herstellung von neuen 5-substituierten oxazolidin-2,4-dionen und ihren salzen
DD251971A5 (de) Verfahren zur herstellung einer pharmazeutisch aktiven oxindol-verbindung
DE2461802A1 (de) Pyrazinderivate
EP0153818B1 (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
DE69305999T2 (de) Oxindol 1-[n-(alkoxycarbonyl)]carboxamide und 1-[n-carboxamido]carboxamide als antiinflammatorische wirkstoffe
DD232039A5 (de) Verfahren zur herstellung einer 2-oxinidol-1-carboxamid-verbindung
DE69720718T2 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
CH633288A5 (de) Verfahren zur herstellung von neuen heterocyclylaminoderivaten.
DD254001A5 (de) Verfahren zur herstellung von heterocyclischen oxophtalazinylessigsaeuren
DE2241027A1 (de) Verfahren zur herstellung neuer heterocyclischer verbindungen
US4808601A (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4752609A (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
DD232916A5 (de) Verfahren zur herstellung von 2-oxindol-1-carboxamiden oder pharmazeutisch akzeptabler salze hiervon
KR870000289B1 (ko) 2-옥스인돌 유도체의 제조방법
DE69005833T2 (de) Entzündungshemmende 1-Heteroaryloxindole-3-Carboxamide.
CA1289556C (en) 1- or 3-monosubstituted 2-oxindole compound intermediates useful for the production of analgesic and anti-inflammatory agents
CA1255657A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti- inflammatory agents
DD232265A5 (de) Verfahren zur herstellung von 2-oxindol-1-carboxamiden und zwischenstufen dafuer

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee